Agios rare blood disorder drug Pyrukynd sustains benefits in long term data
fpm/iStock via Getty Images Agios Pharmaceuticals (NASDAQ:AGIO) said long term data suggested that Pyrukynd led to improvements in hemoglobin, iron…
July 29, 2023
fpm/iStock via Getty Images Agios Pharmaceuticals (NASDAQ:AGIO) said long term data suggested that Pyrukynd led to improvements in hemoglobin, iron…